Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Barnes, Thomas R.E.
and
Edwards, J. Guy
1993.
Antipsychotic Drugs and their Side-Effects.
p.
213.
Kornhuber, J.
and
Weller, M.
1993.
Amantadine and the glutamate hypothesis of schizophrenia Experiences in the treatment of neuroleptic malignant syndrome.
Journal of Neural Transmission,
Vol. 92,
Issue. 1,
p.
57.
Capellà, Dolors
and
Figueras, Albert
1994.
Vol. 18,
Issue. ,
p.
47.
Naber, D.
1995.
Clozapin Pharmakologie und Klinik eines atypischen Neuroleptikums.
p.
1.
Buckley, P F
and
Hutchinson, M
1995.
Neuroleptic malignant syndrome..
Journal of Neurology, Neurosurgery & Psychiatry,
Vol. 58,
Issue. 3,
p.
271.
WELLER, M.
and
KORNHUBER, J.
1996.
Clozapine‐induced neuroleptic malignant syndrome: another inconclusive case report.
Australian and New Zealand Journal of Medicine,
Vol. 26,
Issue. 2,
p.
232.
Ganelin, Luba
Lichtenberg, Pesach S
Marcus, Esther-Lee
and
Munter, R Gabriel
1996.
Suspected Neuroleptic Malignant Syndrome in a Patient Receiving Clozapine.
Annals of Pharmacotherapy,
Vol. 30,
Issue. 3,
p.
248.
Weller, Michael
and
Kornhuber, Johannes
1997.
Clozapine and Neuroleptic Malignant Syndrome.
Journal of Clinical Psychopharmacology,
Vol. 17,
Issue. 3,
p.
233.
Williams, Kelwyn
and
MacPherson, Rob
1997.
Reintroduction of antipsychotics in a patient with clozapine induced neuroleptic malignant syndrome.
Irish Journal of Psychological Medicine,
Vol. 14,
Issue. 4,
p.
147.
Steinberg, R.
Bär-Degitz, M.
Schmook, C.
and
Schneider, C.
1997.
Clozapin.
p.
59.
Oyewumi, L Kola
1999.
Does Lithium Have a Role in the Prevention and Management of Clozapine-Induced Granulocytopenia?.
Psychiatric Annals,
Vol. 29,
Issue. 10,
p.
597.
Caroff, Stanley N
Mann, Stephan C
and
Campbell, E Cabrina
2000.
Atypical Antipsychotics and Neuroleptic Malignant Syndrome.
Psychiatric Annals,
Vol. 30,
Issue. 5,
p.
314.
Carey, S. J.
Hall, D. J.
and
Jones, G. A.
2002.
Grand rounds: catatonia.
Psychiatric Bulletin,
Vol. 26,
Issue. 2,
p.
68.
Shedlack, Karen J.
Levesque, Claire
Charlot, Lauren
Bolduc, Michel
Silka, Van R.
Mikkelsen, Edwin J.
and
Cole, Jonathan O.
2003.
Nothing New under the Sun: Clozapine Rechallenge following a Life-Threatening Medical Event in a Patient with Psychiatric Illness and Developmental Disability.
Harvard Review of Psychiatry,
Vol. 11,
Issue. 6,
p.
334.
Weller, Michael
and
Lehmann-Horn, Frank
2003.
Neurological Disorders.
p.
783.
Kipps, Christopher M.
Fung, Victor S.C.
Grattan‐Smith, Padraic
de Moore, Gregory M.
and
Morris, John G.L.
2005.
Movement disorder emergencies.
Movement Disorders,
Vol. 20,
Issue. 3,
p.
322.
Abad, Josep Maria Haro
2005.
Invited comment.
Acta Psychiatrica Scandinavica,
Vol. 112,
Issue. 3,
p.
240.
Gurrera, Ronald J.
Simpson, John C.
and
Tsuang, Ming T.
2007.
Meta-analytic evidence of systematic bias in estimates of neuroleptic malignant syndrome incidence.
Comprehensive Psychiatry,
Vol. 48,
Issue. 2,
p.
205.
Havaki-Kontaxaki, Beata J.
Ferentinos, Panagiotis P.
Kontaxakis, Vassilis P.
Kontaxaki, Maria-Irini V.
Geronikola, Xenia
Armeniakos, Ioannis
and
Papadimitriou, George N.
2011.
Low-dose clozapine monotherapy for recurring episodes of depression, hypersomnia and behavioural disturbances: a case report.
Acta Neuropsychiatrica,
Vol. 23,
Issue. 4,
p.
191.
Šagud, Marina
Vuksan-Ćusa, Bjanka
Božina, Nada
Lovrić, Mila
Mihaljević-Peleš, Alma
and
Kramarić, Milivoj
2016.
Olanzapine Long-Acting Injections After Neuroleptic Malignant Syndrome.
Journal of Clinical Psychopharmacology,
Vol. 36,
Issue. 6,
p.
733.
eLetters
No eLetters have been published for this article.